Novel PET radiotracer successfully detects multiple cancers, offers potential for new targeted radionuclide therapy

A new radiotracer, 68Ga-FAP-2286, has been found to be more effective than the most commonly used nuclear medicine cancer imaging radiotracer, 18F-FDG. In a study published in the March issue of The Journal of Nuclear Medicine, 68Ga-FAP-2286 detected 100 percent of primary tumors across multiple cancer types as compared to 18F-FDG, which identified only 80 percent. 68Ga-FAP-2286 was also more effective in detecting lymph node metastases and distant metastases.

DNA treatment could delay paralysis that strikes nearly all patients with ALS

In virtually all persons with amyotrophic lateral sclerosis (ALS) and in up to half of all cases of Alzheimer’s disease (AD) and frontotemporal dementia, a protein called TDP-43 is lost from its normal location in the nucleus of the cell. In turn, this triggers the loss of stathmin-2, a protein crucial to regeneration of neurons and the maintenance of their connections to muscle fibers, essential to contraction and movement.

New research suggests AI image generation using DALL-E 2 has promising future in radiology

A new paper published in the Journal of Medical Internet Research describes how generative models such as DALL-E 2, a novel deep learning model for text-to-image generation, could represent a promising future tool for image generation, augmentation, and manipulation in health care. Do generative models have sufficient medical domain knowledge to provide accurate and useful results? Dr. Lisa C Adams and colleagues explore this topic in their latest viewpoint titled “What Does DALL-E 2 Know About Radiology?”

New study examines compromised test conditions and fraudulent data on PCB products in the 1970s

Chronic toxicity tests conducted by Industrial Bio-Test Laboratories (IBT) on behalf of its client Monsanto Corporation revealed information on certain products of the tobacco, asbestos, and lead industries that were found to be toxic. However, the companies were not forthcoming about what they knew about the dangers of these products. This ultimately led to the indictment and conviction of employees of IBT and the Monsanto Corporation.